PBS approval for new once-a-day diabetes medications 9 December 2014 New once-a-day fixed-dose medications for people with type 2 diabetes have been approved for inclusion on the Pharmaceutical Benefits Scheme (PBS). The two new treatments are linagliptin with metformin (sold as Trajenta Duo), and saxagliptin with metformin (sold as Kombiglyze). Federal Health Minister Peter Dutton said that while people with type 2 diabetes already have access to the individual medications through the PBS, some need to use a combination of medicines to treat their diabetes. “With the combination dose now listed on the PBS, these patients will save up to $36.90 every time they get a script filled because they will only have to buy one fixed dose medicine instead of two,†Mr Dutton said. The new treatments are available via prescription. For more information, please contact your doctor or endocrinologist.
News 19 January 2026 National Diabetes Summit to convene at Federal Parliament Australia’s response to one of its most significant health challenges will come into sharp focus at Diabetes Australia’s National Diabetes... Continue Reading
News 16 January 2026 Wegovy to be listed on PBS The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended Wegovy (semaglutide) be subsidised through the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease and obesity. Diabetes Australia’s Group CEO... Continue Reading
Blog 15 January 2026 Five signs it’s time to book a diabetes telehealth appointment Accessing telehealth can be useful if you are newly diagnosed, you feel unwell, or if you are navigating a life transition. Continue Reading
